82 related articles for article (PubMed ID: 9567749)
21. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
22. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
23. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
24. Changes of activity and mRNA expression of urea cycle enzymes in the liver of developing Holstein calves.
Takagi M; Yonezawa T; Haga S; Shingu H; Kobayashi Y; Takahashi T; Ohtani Y; Obara Y; Katoh K
J Anim Sci; 2008 Jul; 86(7):1526-32. PubMed ID: 18344300
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
[TBL] [Abstract][Full Text] [Related]
27. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of amodiaquine and sulfadoxine/pyrimethamine in the treatment of malaria not complicated by Plasmodium falciparum in Nariño, Colombia, 1999-2002].
González IJ; Padilla JO; Giraldo LE; Saravia NG
Biomedica; 2003 Mar; 23(1):38-46. PubMed ID: 12696398
[TBL] [Abstract][Full Text] [Related]
29. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
30. In vivo antimalarial activity of leaves of Plectranthus amboinicus (lour) spreng on Plasmodium berghei yoelii.
Periyanayagam K; Nirmala Devi K; Suseela L; Uma A; Ismail M
J Commun Dis; 2008 Jun; 40(2):121-5. PubMed ID: 19301696
[TBL] [Abstract][Full Text] [Related]
31. Effects of crowding on ornithine-urea cycle enzyme mRNA expression and activity in gulf toadfish (Opsanus beta).
Laberge T; Walsh PJ; McDonald MD
J Exp Biol; 2009 Aug; 212(Pt 15):2394-402. PubMed ID: 19617432
[TBL] [Abstract][Full Text] [Related]
32. Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
Nneji CM; Adaramoye OA; Falade CO; Ademowo OG
Parasitol Res; 2013 Jul; 112(7):2619-25. PubMed ID: 23604568
[TBL] [Abstract][Full Text] [Related]
33. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
[TBL] [Abstract][Full Text] [Related]
35. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria.
Pitmang SL; Thacher TD; Madaki JK; Egah DZ; Fischer PR
Am J Trop Med Hyg; 2005 Mar; 72(3):263-6. PubMed ID: 15772318
[TBL] [Abstract][Full Text] [Related]
37. The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii.
Peters W; Ellis D; Boulard Y; Landau I
Ann Trop Med Parasitol; 1984 Oct; 78(5):467-78. PubMed ID: 6524991
[TBL] [Abstract][Full Text] [Related]
38. Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection.
Kicska GA; Ting LM; Schramm VL; Kim K
J Infect Dis; 2003 Dec; 188(11):1776-81. PubMed ID: 14639551
[TBL] [Abstract][Full Text] [Related]
39. Excretory nitrogen metabolism in the juvenile axolotl Ambystoma mexicanum: differences in aquatic and terrestrial environments.
Loong AM; Chew SF; Ip YK
Physiol Biochem Zool; 2002; 75(5):459-68. PubMed ID: 12529847
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice.
Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC; Puri SK
Drug Chem Toxicol; 2001 May; 24(2):181-90. PubMed ID: 11360434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
